1. Evenity, a monthly injection, is approved to treat osteoporosis is postmenopausal women at high risk of bone fracture.
2. Dovato is a two-drug, fixed-dose complete regimen for HIV patients who have not received antiretroviral treatment.
3. The FDA expanded indication of Ibrance, a metastatic breast cancer treatment, to include male patients.
4. The FDA expanded the label for Keytruda, a cancer immunotherapy drug, as monotherapy for the first-line treatment of patients with stage 3 non-small cell lung cancer who are not able to receive surgical resection of chemoradiation.
More articles on supply chain:
FDA braces for medical device shortages: 9 things to know
Reports of breast implant ‘illness’ spur FDA safety review
5 supply chain technologies to watch
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.